Literature DB >> 11277267

The bone morphogenetic proteins antagonist Noggin inhibits membranous ossification.

P Aspenberg1, C Jeppsson, A N Economides.   

Abstract

Bone morphogenetic proteins (BMPs) are expressed and secreted during fracture repair. Although they are likely to be required for this process, little is known about their physiological role in bone regeneration. Noggin is a protein that specifically binds and inactivates several BMPs. It plays fundamental roles during early embryonal development and limb morphogenesis by this BMP-inactivating activity. This study shows that Noggin can modify bone formation in vivo in the adult animal and, thus, indirectly, that BMP signaling is indispensable in this process. A noggin mutein (hNgdeltaB2-Fc) engineered so as to display increased bioavailability was used. Bilateral titanium bone chambers were inserted in 70 rats, and side comparisons for bone formation in the chambers were done. The hNgdeltaB2-Fc had no effect on total amount of tissue formed in the chamber but decreased the amount of bone compared with both buffer controls and a control made up of an Fc-tagged IL-6Ralpha protein, which had no effects of its own. Also, wild-type noggin inhibited bone formation. Thus, endogenous BMP signaling is necessary for normal bone regeneration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277267     DOI: 10.1359/jbmr.2001.16.3.497

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  22 in total

1.  Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.

Authors:  Ruth Schwaninger; Cyrill A Rentsch; Antoinette Wetterwald; Geertje van der Horst; Rutger L van Bezooijen; Gabri van der Pluijm; Clemens W G M Löwik; Karin Ackermann; Walter Pyerin; Freddie C Hamdy; George N Thalmann; Marco G Cecchini
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  RNA interfering molecule delivery from in situ forming biodegradable hydrogels for enhancement of bone formation in rat calvarial bone defects.

Authors:  Minh K Nguyen; Oju Jeon; Phuong N Dang; Cong T Huynh; Davood Varghai; Hooman Riazi; Alexandra McMillan; Samuel Herberg; Eben Alsberg
Journal:  Acta Biomater       Date:  2018-06-07       Impact factor: 8.947

3.  Distinct functionalities of bone morphogenetic protein antagonists during fracture healing in mice.

Authors:  Daniel B Dean; John T Watson; Wu Jin; Charlie Peters; J T Enders; Andrew Chen; Berton R Moed; Zijun Zhang
Journal:  J Anat       Date:  2010-03-05       Impact factor: 2.610

Review 4.  Agonists and Antagonists of TGF-β Family Ligands.

Authors:  Chenbei Chang
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

5.  [Osteogenic effect of collagen/bioglass composites carrying noggin siRNA].

Authors:  Yanling Chen; Liangjiao Chen; Zhengmao Li; Zedong Lan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-01-30

6.  Dual delivery of rhPDGF-BB and bone marrow mesenchymal stromal cells expressing the BMP2 gene enhance bone formation in a critical-sized defect model.

Authors:  Shin-Young Park; Kyoung-Hwa Kim; Seung-Yun Shin; Ki-Tae Koo; Yong-Moo Lee; Yang-Jo Seol
Journal:  Tissue Eng Part A       Date:  2013-07-31       Impact factor: 3.845

7.  Endogenous BMPR-IB signaling is required for early osteoblast differentiation of human bone cells.

Authors:  Weerachai Singhatanadgit; Irwin Olsen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-12-07       Impact factor: 2.416

8.  Nanoparticulate mineralized collagen scaffolds induce in vivo bone regeneration independent of progenitor cell loading or exogenous growth factor stimulation.

Authors:  Xiaoyan Ren; Victor Tu; David Bischoff; Daniel W Weisgerber; Michael S Lewis; Dean T Yamaguchi; Timothy A Miller; Brendan A C Harley; Justine C Lee
Journal:  Biomaterials       Date:  2016-02-18       Impact factor: 12.479

9.  Noggin gene delivery inhibits cementoblast-induced mineralization.

Authors:  Q-M Jin; M Zhao; A N Economides; M J Somerman; W V Giannobile
Journal:  Connect Tissue Res       Date:  2004       Impact factor: 3.417

10.  Prophylaxis of heterotopic ossification - an updated review.

Authors:  Evan O Baird; Qian K Kang
Journal:  J Orthop Surg Res       Date:  2009-04-20       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.